News Article
Candesic examines the phenomenon of synthetic human embryos
23 October 2023
Dr Leonid Shapiro, Managing Partner at Candesic, and Dr Joe Taylor, principal at Candesic, examine the phenomenon of synthetic human embryos in the latest PharmaTimes Media Ltd. Developing clear and rigorous regulatory frameworks for synthetic human embryos will be crucial to the development of their potential uses.